# A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

> **NCT07716410** · — · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Cryptosporidiosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07716410
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-09
- **Primary completion:** 2027-05-19
- **Final completion:** 2027-05-19
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07716410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07716410, "A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07716410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*